eversense

Senseonics, TypeZero and Roche Diabetes Care team-up to trial a long-term artificial pancreas system

The trial will integrate Senseonics' Eversense CGM System with TypeZero's inControl AP algorithms and Roche's Accu-Chek Insight Insulin Pump.